Treatment of Meibomian Gland Dysfunction and Dry Eye in Contact Lens Wearers

Completed · Not applicable

Conditions studied: Meibomian Gland Dysfunction, Dry Eye

In brief

The pilot study objective is to evaluate the potential benefits of LipiFlow® System treatment of contact lens wearers with meibomian gland dysfunction and evaporative dry eye by assessing for improvement in meibomian gland function and reduction of dry eye symptoms in comparison to an untreated control.

Key facts

Study ID
NCT02102464
Run by
TearScience, Inc.
People needed
55
Starts
2014-04-01
Expected to finish
2015-09-01
Last updated by the study team
2017-10-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.